Main aim is to evaluate the role of stress in the evolution of inflammatory bowel disease (IBD) and the quality of life of these patients. A second aim is to establish the existence of any psicopathological profile in these patients. We designed a prospective experimental study were patients are randomized to receive or not a cognitive-behavior program. Patients will be evaluated at 3 and 12 months after the program and study variables will be measured: stress level, coping strategies, quality of life, activity of disease and biological variables related to IBD.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
220
Department of health psychology. Hospital General Universitario de Alicante
Alicante, Spain
Change in IBD activity at short and long-term
Number of clinical episodes of activity of IBD
Time frame: Measured at baseline, and evaluation at short-term (3 months) and long-term 12 months
Change in IBD activity at short and long-term
Number of hospital admisions because of IBD
Time frame: Measured at baseline, and evaluation at short-term (3 months) and long-term 12 months
Change in IBD activity at short and long-term
Activity index vaules (CDAI for Crohn's disease and Mayo score for ulcerative colitis)
Time frame: Measured at baseline, and evaluation at short-term (3 months) and long-term 12 months
Change in stress scales at short and long-term
Perceived Stress Scale (PSS)
Time frame: Measured at baseline, and evaluation at short-term (3 months) and long-term 12 months
Change in quality of life at short and long-term
Inflammatory bowel disease quality-of-life scale (IBDQ)
Time frame: Measured at baseline, and evaluation at short-term (3 months) and long-term 12 months
Change in anxiety and depression at short and long-term
HAD scale
Time frame: Measured at baseline, and evaluation at short-term (3 months) and long-term 12 months
Change in stress scales at short and long-term
Disease related stress scale (EAE)
Time frame: Measured at baseline, and evaluation at short-term (3 months) and long-term 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Change in stress scales at short and long-term
Vital stressors scale (AVE)
Time frame: Measured at baseline, and evaluation at short-term (3 months) and long-term 12 months
Change in stress scales at short and long-term
stress coping questionnaire (CAE)
Time frame: Measured at baseline, and evaluation at short-term (3 months) and long-term 12 months